Ecron Acunova Announces Key Leadership Change – Marty Boom appointed as Managing Director
Ecron Acunova, a subsidiary of TAKE Solutions and specialized provider of clinical services to Pharma & Biotech companies, announced the appointment of Marty Boom as Managing Director.
Mr. Boom takes over this position from his former role as Head of Operations of TAKE Solutions’ Life Sciences brand Navitas, where he made significant contributions to the growth of the organization with his leadership spanning both the US and India geographies. Mr. Boom has rich experience in managing diverse global teams and has led global business improvement assignments for companies like Bayer HealthCare, Pfizer, Johnson & Johnson, Roche, and many others in most areas of Pharmaceutical Drug Development and Supply Chain. Mr. Boom will be based at the Headquarters in Frankfurt, Germany.
About Ecron Acunova
Ecron Acunova (www.ecronacunova.com ) is a full service CRO with predominant presence in Europe and Asia with 30 years of track record. EA offers full-service clinical research including clinical operations, data management, biostatistics, pharmacovigilance, PK/PD services and central lab to pharma, biotech, medical device, nutrition and diagnostic companies.
Ecron Acunova is a wholly owned subsidiary of TAKE Solutions Ltd .
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
FL-MLB22.9.2018 00:15 | pressemeddelelse
American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)
NY-BCW/PALLADINO21.9.2018 19:45 | pressemeddelelse
Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice
HEIDELBERG-ENGINEERING21.9.2018 18:43 | pressemeddelelse
Heidelberg Engineering Announces the CE-Marking of ANTERION
JEDOX21.9.2018 17:48 | pressemeddelelse
Florian Winterstein Becomes New CEO of Jedox
AVINOR21.9.2018 16:39 | pressemeddelelse
Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter
MA-TAKEDA-PHARMACEUTICAL21.9.2018 15:32 | pressemeddelelse
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum